News and Announcements
As one of the top five pharmaceutical companies in Australia, Wyeth plays an important role in the provision of quality treatments that improve the health and wellbeing of Australians.
Wyeth has developed clear positions on a range of current healthcare issues such as reform of the Pharmaceutical Benefits Scheme and ensuring Australians have information about, and timely access to, the latest innovative treatments for themselves and their families.
News and Announcements
September 26, 2008- Wyeth Comments on the Current Infant Formula Situation in China
- September 05, 2008
- Shortland Street Badboy Has a New 'Habit ' for Kiwi Kids
- March 13, 2007
- Wyeth Builds on Commitment to Innovation in Haemophilia
- March 13, 2007
- Wyeth Seeks to Further its Innovation in Haemophilia
- February 24, 2006
- Warning on Looming Health Crisis: Infectious Disease Specialist
Fast Facts
- If one parent has psoriasis, children have a 10 percent to 25 percent chance of developing psoriasis.
- Did you know it costs approximately $1.2 billion to bring a new product to market?
- The Pharmaceutical industry employs more than 30,000 Australians, supporting both the economy and the health of Australians.
